Neuigkeiten in der Krebstherapie

2018

Abemaciclib/Pembrolizumab Combo Shows Early Promise for HR+/HER2- Breast Cancer

14. August

Read more

IMpower133: Atezolizumab in Combination With Chemotherapy in Previously Untreated, Extensive-Stage Small Cell Lung Cancer

19. July

Read more

IMpassion130: Atezolizumab Plus Nab-Paclitaxel in Metastatic or Locally Advanced Triple-Negative Breast Cancer

15. July

Read more

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer.

11. June

Read more

Immune-System Therapy Eradicated Breast Cancer in New Breakthrough

11. June

Read more

Immunotherapy and radiation in glioblastoma.

11. May

Read more

Prognostic significance of marital status in breast cancer survival: A population-based study.

01. April

Read more

Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

23. March

Read more

Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.

28. February

Read more

Physician age and outcomes in elderly patients in hospital in the US: observational study

05. February

Read more

Proof-of-Principle Study of Combination Checkpoint Inhibitor Plus Trastuzumab in HER2-Positive Advanced Breast Cancer

30. January

Read more

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

26. January

Read more

Preventive Effects of Cocoa and Cocoa Antioxidants in Colon Cancer

20. January

Read more

American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance)

20. January

Read more

Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer

18. January

Read more

FDA Grants DS-8201 Breakthrough Designation for HER2+ Breast Cancer

15. January

Read more

2017

Clinical decision-making for immunotherapy in metastatic renal cell carcinoma

28. October

Read more

Osimertinib Granted Breakthrough Therapy Designation for First-Line Treatment of EGFR Mutation–Positive NSCLC

22. October

Read more

Cancers Associated With Overweight and Obesity Make Up 40% of Cancers Diagnosed in the United States

19. October

Read more

FDA Approves Daratumumab in Combination With Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

25. September

Read more

The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme

19. September

Read more

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

06. September

Read more

FDA Approves Panitumumab for Use in Wild-Type RAS Metastatic Colorectal Cancer

05. September

Read more

Angiosarcoma treated successfully with anti-PD-1 therapy - a case report

20. July

Read more

Genentech: Beyond The Cycle

12. June

Read more

Cancer Drug Proves to Be Effective Against Multiple Tumors

10. June

Read more

Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer

08. June

Read more

ASCO 2017: Chance of Colon Cancer Recurrence Nearly Cut in Half in Patients Who Consume Nuts

06. June

Read more

Checkpoint Inhibitors Advancing in Multiple GI Cancers

03. June

Read more

Duke researchers develop treatment that triples survival time of brain cancer patients

31. May

Read more

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

31. May

Read more

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

13. May

Read more

Brain Trust: Cutting-Edge Treatments for Glioblastoma on the Rise

17. April

Read more

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

13. May

Read more

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

16. April

Read more

Nivolumab in renal cell carcinoma: latest evidence and clinical potential

02. April

Read more

Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer

12. March

Read more

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

08. March

Read more

Ovarian cancer and the immune system — The role of targeted therapies

07. March

Read more

Nivolumab in patients with DNA mismatch repair deficient/microsatellite instability high metastatic colorectal cancer: Update from CheckMate 142

21. February

Read more

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma: an international, multicentre, open-label, phase 2 trial.

08. February

Read more

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

05. February

Read more

2016

Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report

16. November

Read more

Immunotherapy moves to the front lines in fight against lung cancer

13. November

Read more

Impressive Early Data for Rovalpituzumab Tesirine in Small Cell Lung Cancer

09. November

Read more

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

24. October

Read more

The Science Behind Guided Imagery

12. October

Read more

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

16. September

Read more

The development and use of the E75 (HER2 369-377) peptide vaccine

27. August

Read more

Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial

27. August

Read more

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

18. August

Read more

Harnessing the immune system to fight cancer

01. August

Read more

Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide

13. July

Read more

Neoadjuvant T-DM1/Pertuzumab Combo Boosts pCR in HER2+ Breast Cancer

26. April

Read more

Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors

14. April

Read more

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial

14. April

Read more

Peptide vaccines in breast cancer: The immunological basis for clinical response

10. March

Read more

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial

25. February

Read more

With Immunotherapy, Glimmers of Progress against Glioblastoma

23. January

Read more

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

15. January

Read more

2015

Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers

22. November

Read more

Adjuvant HER2/neu peptide cancer vaccines in breast cancer

22. November

Read more

Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study

09. October

Read more

Immune modulation for cancer therapy

08. October

Read more

Case report: A breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapy

02. October

Read more

Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.

02. October

Read more

Cancer immunotherapy with peptide-based vaccines: What have we achieved? Where are we going?

30. September

Read more